• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.41% Nasdaq Up 0.52%

    TG Therapeutics, Inc. (TGTX)

    -NasdaqCM
    16.34 Up 0.53(3.35%) 3:07PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:15.81
    Open:16.15
    Bid:16.21 x 200
    Ask:16.24 x 100
    1y Target Est:23.80
    Beta:-0.55
    Next Earnings Date:N/A
    Day's Range:15.87 - 16.58
    52wk Range:4.42 - 20.00
    Volume:308,442
    Avg Vol (3m):591,961
    Market Cap:734.19M
    P/E (ttm):N/A
    EPS (ttm):-1.64
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TGTX

    Comparison

    Symbol% ChgMkt Cap
    TGTXUp 3.35%734.19M
    BIIBDown 0.17%99.05B
    CELGUp 0.08%91.94B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4,661.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.43
    Quarterly EPS Est (Mar-15) :-0.33
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for b-cell malignancies and autoimmune diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback